0
0
Home » Medical Devices » Anesthesia and Respiratory Devices

Respiratory Assist Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Respiratory Assist Devices facilitate breathing during respiratory failure and other respiratory disease conditions. GlobalData's Medical Devices sector report, “Respiratory Assist Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" provides comprehensive information about the Respiratory Assist Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Respiratory Assist Devices report provides key information and data related to:

Extensive coverage of the Respiratory Assist Devices under development

Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates

Reviews of major players involved in the pipeline product development.

Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and the number of trials of the major Respiratory Assist Devices pipeline products.

Review of Recent Developments in the segment / industry

The Respiratory Assist Devices report enables you to:

Access significant competitor information, analysis, and insights to improve your R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage

Identify and understand important and diverse types of Respiratory Assist Devices under development

Formulate market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

The GlobalData Differentiation

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:

• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025

• 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports

• 64,000+ medical equipment company profiles

• 5,600+ company profiles of medical equipment manufacturers in China and India

• 2,200+ company profiles of medical equipment manufacturers in Japan

• 1,200+ companies’ revenue splits and market shares

• 1,600+ quarterly and annual medical equipment company financials

• 850+ medical equipment company SWOTs

• 28,000+ pipeline product profiles

• 56,400+ marketed product profiles

• 47,000+ clinical trials

• 41,500+ trial investigators

• 7,000+ reports on companies with products in development

• 44,000+ deals in the medical equipment industry

• 1,100+ surgical and diagnostic procedures by therapy area

• 50+ key healthcare indicators by country

• 431,000+ Themes Content Items

• 600+ Influencers

• 1,900+ Analysts & Researchers

• 0.5m+ Community Members

• 141,000+ Macroeconomic Indicators

• 1,013,000+ City Indicators

For more information or to receive a free demonstration of the service, please visit:

https://medical.globaldata.com/home.aspx

Custom Requirements

Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

– Extensive coverage of the Respiratory Assist Devices under development

– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

– The report reviews the major players involved in the development of Respiratory Assist Devices and list all their pipeline projects

– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

– The report provides key clinical trial data of ongoing trials specific to pipeline products

– Recent developments in the segment / industry

Reasons to Buy

The report enables you to:

– Formulate significant competitor information, analysis, and insights to improve R&D strategies

– Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage

– Identify and understand important and diverse types of Respiratory Assist Devices under development

– Develop market-entry and market expansion strategies

– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

– In-depth analysis of the product’s current stage of development, territory and estimated launch date

Key Players

Advanced Respiratory Technologies LLC

ALung Technologies Inc

Baxter Healthcare Corp

Bellco Srl

Belluscura Plc

Braile Biomedica Ltda

Breethe, Inc.

Case Western Reserve University

enmodes GmbH

Liberate Medical LLC

Lung Biotechnology PBC

MAQUET Cardiopulmonary AG

MC3 Inc

McGowan Institute for Regenerative Medicine

Minnesota Health Solutions Corporation

Miromatrix Medical Inc

Postgraduate Institute of Medical Education and Research

Rice University

The Charles Stark Draper Laboratory Inc

TVS Group

U.S. Ann Arbor Healthcare System

University of Arizona

University of California Los Angeles

University of Michigan

University of Pittsburgh

Veterans Health Administration

X-COR Therapeutics

Xenios AG

Table of Contents

1 Table of Contents 3

|1.1 List of Tables 5

|1.2 List of Figures 8

2 Introduction 9

2.1 Respiratory Assist Devices Overview 9

3 Products under Development 10

3.1 Respiratory Assist Devices – Pipeline Products by Stage of Development 10

3.2 Respiratory Assist Devices – Pipeline Products by Segment 11

3.3 Respiratory Assist Devices – Pipeline Products by Territory 12

3.4 Respiratory Assist Devices – Pipeline Products by Regulatory Path 13

3.5 Respiratory Assist Devices – Pipeline Products by Estimated Approval Date 14

3.6 Respiratory Assist Devices – Ongoing Clinical Trials 15

4 Respiratory Assist Devices – Pipeline Products under Development by Companies 16

4.1 Respiratory Assist Devices Companies – Pipeline Products by Stage of Development 16

4.2 Respiratory Assist Devices – Pipeline Products by Stage of Development 18

5 Respiratory Assist Devices Companies and Product Overview 20

5.1 Advanced Respiratory Technologies LLC Company Overview 20

5.1.1 Advanced Respiratory Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 20

5.2 ALung Technologies Inc Company Overview 21

5.2.1 ALung Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 21

5.3 Baxter Healthcare Corp Company Overview 25

5.3.1 Baxter Healthcare Corp Pipeline Products & Ongoing Clinical Trials Overview 25

5.4 Bellco Srl Company Overview 28

5.4.1 Bellco Srl Pipeline Products & Ongoing Clinical Trials Overview 28

5.5 Belluscura Plc Company Overview 29

5.5.1 Belluscura Plc Pipeline Products & Ongoing Clinical Trials Overview 29

5.6 Braile Biomedica Ltda Company Overview 30

5.6.1 Braile Biomedica Ltda Pipeline Products & Ongoing Clinical Trials Overview 30

5.7 Breethe, Inc. Company Overview 31

5.7.1 Breethe, Inc. Pipeline Products & Ongoing Clinical Trials Overview 31

5.8 Case Western Reserve University Company Overview 33

5.8.1 Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview 33

5.9 enmodes GmbH Company Overview 34

5.9.1 enmodes GmbH Pipeline Products & Ongoing Clinical Trials Overview 34

5.10 Liberate Medical LLC Company Overview 35

5.10.1 Liberate Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 35

5.11 Lung Biotechnology PBC Company Overview 36

5.11.1 Lung Biotechnology PBC Pipeline Products & Ongoing Clinical Trials Overview 36

5.12 MAQUET Cardiopulmonary AG Company Overview 38

5.12.1 MAQUET Cardiopulmonary AG Pipeline Products & Ongoing Clinical Trials Overview 38

5.13 MC3 Inc Company Overview 39

5.13.1 MC3 Inc Pipeline Products & Ongoing Clinical Trials Overview 39

5.14 McGowan Institute for Regenerative Medicine Company Overview 40

5.14.1 McGowan Institute for Regenerative Medicine Pipeline Products & Ongoing Clinical Trials Overview 40

5.15 Minnesota Health Solutions Corporation Company Overview 45

5.15.1 Minnesota Health Solutions Corporation Pipeline Products & Ongoing Clinical Trials Overview 45

5.16 Miromatrix Medical Inc Company Overview 46

5.16.1 Miromatrix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 46

5.17 Postgraduate Institute of Medical Education and Research Company Overview 47

5.17.1 Postgraduate Institute of Medical Education and Research Pipeline Products & Ongoing Clinical Trials Overview 47

5.18 Rice University Company Overview 48

5.18.1 Rice University Pipeline Products & Ongoing Clinical Trials Overview 48

5.19 The Charles Stark Draper Laboratory Inc Company Overview 49

5.19.1 The Charles Stark Draper Laboratory Inc Pipeline Products & Ongoing Clinical Trials Overview 49

5.20 TVS Group Company Overview 50

5.20.1 TVS Group Pipeline Products & Ongoing Clinical Trials Overview 50

5.21 U.S. Ann Arbor Healthcare System Company Overview 51

5.21.1 U.S. Ann Arbor Healthcare System Pipeline Products & Ongoing Clinical Trials Overview 51

5.22 University of Arizona Company Overview 52

5.22.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 52

5.23 University of California Los Angeles Company Overview 53

5.23.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 53

5.24 University of Michigan Company Overview 54

5.24.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 54

5.25 University of Pittsburgh Company Overview 55

5.25.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 55

5.26 Veterans Health Administration Company Overview 57

5.26.1 Veterans Health Administration Pipeline Products & Ongoing Clinical Trials Overview 57

5.27 X-COR Therapeutics Company Overview 59

5.27.1 X-COR Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 59

5.28 Xenios AG Company Overview 60

5.28.1 Xenios AG Pipeline Products & Ongoing Clinical Trials Overview 60

6 Respiratory Assist Devices- Recent Developments 61

6.1 May 17, 2022: Soleno Therapeutics to Participate in the H.C. Wainwright Global Investment Conference 61

6.2 May 02, 2022: Teleflex to Host Analyst & Investor Day on May 20, 2022 61

6.3 Apr 28, 2022: Teleflex Reports First Quarter Financial Results And Full Year Outlook 61

6.4 Apr 19, 2022: Miromatrix CEO Jeff Ross to Present at the 2022 Cell & Gene Meeting on the Med 63

6.5 Apr 14, 2022: Inogen to Announce First Quarter 2022 Financial Results on May 5, 2022 63

6.6 Mar 31, 2022: Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2021 Financial Results 64

6.7 Mar 29, 2022: Miromatrix Moves into New Headquarters Complete with In-House Manufacturing Capabilities 65

6.8 Mar 17, 2022: Miromatrix to Report Fourth Quarter and Full Year 2021 Financial Results 66

6.9 Mar 01, 2022: Miromatrix Names Jim Douglas as New Chief Financial Officer 66

6.10 Feb 24, 2022: Teleflex Announces Fourth Quarter and Full-Year 2021 Financial Results 67

6.11 Feb 08, 2022: Soleno Therapeutics to Participate in the BIO CEO & Investor Conference 68

6.12 Jan 26, 2022: Inogen to Announce Fourth Quarter 2021 Financial Results on February 24, 2022 68

6.13 Jan 05, 2022: Soleno Therapeutics to Participate in the LifeSci Partners 11th Annual Corporate Access Event 69

6.14 Nov 18, 2021: Teleflex to Participate in the 33rd Annual Virtual Piper Sandler Healthcare Conference 69

6.15 Oct 28, 2021: Teleflex Reports Third Quarter 2021 Results and Full Year Outlook 69

6.16 Oct 14, 2021: Teleflex Announces Third Quarter 2021 Earnings Conference Call Information 73

6.17 Oct 13, 2021: Inogen to Announce Third Quarter 2021 Financial Results on November 4, 2021 73

6.18 Sep 23, 2021: Soleno Therapeutics to Participate in the 2021 Cantor Virtual Global Healthcare Conference 74

6.19 Sep 22, 2021: The international standard proposed by experts from BMC Medical in terms of high-flow respiratory therapy equipment officially released 74

6.20 Sep 01, 2021: Teleflex to Present at the Morgan Stanley 19th Annual Global Healthcare Conference 74

6.21 Aug 26, 2021: Teleflex to Present at the Wells Fargo 2021 Virtual Healthcare Conference 74

6.22 Aug 04, 2021: Inogen Announces Second Quarter 2021 Financial Results 75

6.23 Jul 29, 2021: Draper develops artificial lung technology with $4.9M U.S. army grant, earns ASAIO award 77

6.24 Jul 28, 2021: Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2021 Financial Results 78

6.25 Jul 14, 2021: Inogen to Announce Second Quarter 2021 Financial Results on August 4, 2021 80

6.26 Jul 13, 2021: Xenios receives approval in China for ECMO devices 80

6.27 Jun 08, 2021: Inogen announces appointment of chief medical officer 81

7 Appendix 82

7.1 Methodology 82

7.2 About GlobalData 84

7.3 Contact Us 85

7.4 Disclaimer 85

List of Tables

Respiratory Assist Devices – Pipeline Products by Stage of Development 10

Respiratory Assist Devices – Pipeline Products by Segment 11

Respiratory Assist Devices – Pipeline Products by Territory 12

Respiratory Assist Devices – Pipeline Products by Regulatory Path 13

Respiratory Assist Devices – Pipeline Products by Estimated Approval Date 14

Respiratory Assist Devices – Ongoing Clinical Trials 15

Respiratory Assist Devices Companies – Pipeline Products by Stage of Development 16

Respiratory Assist Devices – Pipeline Products by Stage of Development 18

Advanced Respiratory Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 20

Pulmonary Assist Device – Product Status 20

Pulmonary Assist Device – Product Description 20

ALung Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 21

Hattler Catheter – Product Status 21

Hattler Catheter – Product Description 21

Next Generation Artificial Lung – Product Status 22

Next Generation Artificial Lung – Product Description 22

ULFED – <1L/min – Product Status 22

ULFED – <1L/min – Product Description 23

ULFED – 250 mL/min – Product Status 23

ULFED – 250 mL/min – Product Description 24

Baxter Healthcare Corp Pipeline Products & Ongoing Clinical Trials Overview 25

PrismaLung+ – Product Status 25

PrismaLung+ – Product Description 25

Baxter Healthcare Corp – Ongoing Clinical Trials Overview 26

PrismaLung+ – A Novel ECCO2R Device as a Lung Protective Measure in Hypercapnic Respiratory Failure: A Prospective Multicenter Trial 27

PrismaLung+ – A Post-market Study of Performance and Safety of Low-flow Extracorporeal Carbon Dioxide Removal Using PrismaLung+ in Patients with Mild to Moderate Acute Respiratory Distress Syndrome 27

Bellco Srl Pipeline Products & Ongoing Clinical Trials Overview 28

Abylcap – Product Status 28

Abylcap – Product Description 28

Belluscura Plc Pipeline Products & Ongoing Clinical Trials Overview 29

Portable Artificial Lung – Product Status 29

Portable Artificial Lung – Product Description 29

Braile Biomedica Ltda Pipeline Products & Ongoing Clinical Trials Overview 30

Artificial Respirator – Product Status 30

Artificial Respirator – Product Description 30

Breethe, Inc. Pipeline Products & Ongoing Clinical Trials Overview 31

Abiomed Breethe OXY-1 System – Product Status 31

Abiomed Breethe OXY-1 System – Product Description 32

Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview 33

Portable Artificial Lung – Product Status 33

Portable Artificial Lung – Product Description 33

enmodes GmbH Pipeline Products & Ongoing Clinical Trials Overview 34

RAS-Q – Product Status 34

RAS-Q – Product Description 34

Liberate Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 35

SecondBreath – Product Status 35

SecondBreath – Product Description 35

Lung Biotechnology PBC Pipeline Products & Ongoing Clinical Trials Overview 36

3D Bioprinted Lung Transplant – Product Status 36

3D Bioprinted Lung Transplant – Product Description 36

XenoLung – Product Status 37

XenoLung – Product Description 37

MAQUET Cardiopulmonary AG Pipeline Products & Ongoing Clinical Trials Overview 38

PALP – Product Status 38

PALP – Product Description 38

MC3 Inc Pipeline Products & Ongoing Clinical Trials Overview 39

BioLung – Product Status 39

BioLung – Product Description 39

McGowan Institute for Regenerative Medicine Pipeline Products & Ongoing Clinical Trials Overview 40

A – modELAS – Product Status 40

A – modELAS – Product Description 41

A,P- modELAS – Product Status 41

A,P- modELAS – Product Description 41

Biohybrid Artificial Lung – Product Status 42

Biohybrid Artificial Lung – Product Description 42

Chronic Artificial Lung – Product Status 42

Chronic Artificial Lung – Product Description 43

Impeller Percutaneous Respiratory Assist Catheter (iPRAC) – Product Status 43

Impeller Percutaneous Respiratory Assist Catheter (iPRAC) – Product Description 43

P-modelas – Product Status 44

P-modelas – Product Description 44

Minnesota Health Solutions Corporation Pipeline Products & Ongoing Clinical Trials Overview 45

Non-Invasive Ventilator Respiratory Interface – Product Status 45

Non-Invasive Ventilator Respiratory Interface – Product Description 45

Miromatrix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 46

Mirolung – Product Status 46

Mirolung – Product Description 46

Postgraduate Institute of Medical Education and Research Pipeline Products & Ongoing Clinical Trials Overview 47

SMARTS – COVID-19 – Product Status 47

SMARTS – COVID-19 – Product Description 47

Rice University Pipeline Products & Ongoing Clinical Trials Overview 48

Respiratory Assist Device – Product Status 48

Respiratory Assist Device – Product Description 48

The Charles Stark Draper Laboratory Inc Pipeline Products & Ongoing Clinical Trials Overview 49

Silicone-Based Microfluidic Artificial Lung – Product Status 49

Silicone-Based Microfluidic Artificial Lung – Product Description 49

TVS Group Pipeline Products & Ongoing Clinical Trials Overview 50

Sundaram Ventago – Product Status 50

Sundaram Ventago – Product Description 50

U.S. Ann Arbor Healthcare System Pipeline Products & Ongoing Clinical Trials Overview 51

3D-Printed Artificial Lung – Product Status 51

3D-Printed Artificial Lung – Product Description 51

University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 52

HeCOS – Product Status 52

HeCOS – Product Description 52

University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 53

Percutaneous Catheter for Lung Assist Device – Product Status 53

Percutaneous Catheter for Lung Assist Device – Product Description 53

University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 54

M-Lung – Product Status 54

M-Lung – Product Description 54

University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 55

P-PAL – Product Status 55

P-PAL – Product Description 55

Paracorporeal Ambulatory Assist Lung – Product Status 56

Paracorporeal Ambulatory Assist Lung – Product Description 56

Veterans Health Administration Pipeline Products & Ongoing Clinical Trials Overview 57

3D Printed Microfluidic Artificial Lung – Product Status 57

3D Printed Microfluidic Artificial Lung – Product Description 57

Artificial Lung – Product Status 58

Artificial Lung – Product Description 58

X-COR Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 59

Extracorporeal CO2 Removal Device – Product Status 59

Extracorporeal CO2 Removal Device – Product Description 59

Xenios AG Pipeline Products & Ongoing Clinical Trials Overview 60

i-lung – Product Status 60

i-lung – Product Description 60

Glossary 84

List of Figures

Respiratory Assist Devices – Pipeline Products by Stage of Development 9

Respiratory Assist Devices – Pipeline Products by Segment 10

Respiratory Assist Devices – Pipeline Products by Territory 11

Respiratory Assist Devices – Pipeline Products by Regulatory Path 12

Respiratory Assist Devices – Pipeline Products by Estimated Approval Date 13

Respiratory Assist Devices – Ongoing Clinical Trials 14

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2960

Join our mailing list

Saved reports